Statements (33)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
hemostatic agent antifibrinolytic agent |
| gptkbp:ATCCode |
B02AA01
|
| gptkbp:brand |
Amicar
|
| gptkbp:CASNumber |
60-32-2
|
| gptkbp:chemicalFormula |
C6H13NO2
|
| gptkbp:contraindication |
active intravascular clotting
|
| gptkbp:discoveredBy |
1950s
|
| gptkbp:eliminationHalfLife |
2 hours
|
| gptkbp:excretion |
renal
|
| gptkbp:FDAApproved |
1970s
|
| https://www.w3.org/2000/01/rdf-schema#label |
Aminocaproic acid
|
| gptkbp:IUPACName |
6-aminohexanoic acid
|
| gptkbp:mechanismOfAction |
inhibits plasminogen activation
|
| gptkbp:meltingPoint |
205 °C
|
| gptkbp:metabolism |
minimal
|
| gptkbp:molecularWeight |
131.17 g/mol
|
| gptkbp:PubChem_CID |
564
CHEBI:16330 DB00513 |
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:sideEffect |
nausea
vomiting muscle weakness hypotension |
| gptkbp:solubility |
soluble in water
|
| gptkbp:UNII |
UQN9U3XW3D
|
| gptkbp:usedFor |
prevention of fibrinolysis
treatment of excessive bleeding |
| gptkbp:bfsParent |
gptkb:Thrombolytics
|
| gptkbp:bfsLayer |
7
|